Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy for cardiac diseases.

Emerson C Perin1, Guilherme V Silva

  • 1Department of Adult Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas, USA. eperin@crescentb.net

Current Opinion in Hematology
|November 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.

American heart journal·2025
Same author

Cardiac Progenitor Cells in HLHS: Feasibility Now, Efficacy Next?

JACC. Heart failure·2025
Same author

Cell therapy for heart failure -recent progress and future directions.

Progress in cardiovascular diseases·2025
Same author

Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF.

European journal of heart failure·2024
Same author

Radiation exposure during distal and traditional radial coronary angiography and percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

The Journal of invasive cardiology·2023
Same author

Leadless pacemaker with transcatheter aortic valve implantation: A single-center experience.

Pacing and clinical electrophysiology : PACE·2023
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Stem cell therapy shows promise for cardiac disease, with bone marrow stem cells being a leading option. Further research is needed to fully understand its mechanisms and optimize patient selection for safety and efficacy.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biomedical Engineering

Background:

  • Stem cell therapy is an emerging treatment for cardiac conditions.
  • Key questions remain regarding its application, including patient selection, safety, cell type, delivery methods, cell fate, and therapeutic mechanisms.

Purpose of the Study:

  • To review recent advancements in understanding stem cell therapy for cardiac disease.
  • To address fundamental questions about patient selection, safety, cell type, delivery, cell fate, and mechanism of action.

Main Methods:

  • Literature review of preclinical and clinical findings over the past year.
  • Analysis of current knowledge on stem cell therapy for acute myocardial infarction and chronic ischemic heart failure.

Related Experiment Videos

Main Results:

  • Bone marrow stem cells are currently favored for cardiac applications.
  • Delivery methods include surgical injection, intracoronary infusion, and transendocardial injection.
  • Potential benefits include increased cardiac contractility and limited infarct remodeling; accelerated atherogenesis is a concern.

Conclusions:

  • Stem cell therapy holds significant potential for treating cardiac diseases.
  • The field is rapidly evolving with accumulating evidence supporting its efficacy.
  • Substantial knowledge gaps persist, hindering widespread clinical application.